Thursday, October 10, 2019 4:48:38 PM
I have downloaded these documents and hosted them in an AWS S3 bucket so that all of you can access them free of charge. You are free to read them and form your own opinions.
IVDN's motion to strike is here: https://ivdn-pacerdocuments.s3-us-west-2.amazonaws.com/IVDN_MotionToStrike.pdf
The FTC's response is here: https://ivdn-pacerdocuments.s3-us-west-2.amazonaws.com/FTC_OppositionToMotionToStrike.pdf
IVDN's reply is here: https://ivdn-pacerdocuments.s3-us-west-2.amazonaws.com/IVDN_ReplyToOppositionToMotionToStrike.pdf
And the FTC's final reply is here: https://ivdn-pacerdocuments.s3-us-west-2.amazonaws.com/FTC_SurReply.pdf
Much of the discussion revolves around not whether Yarborough's testimony is accurate, but whether it is legally admissible and the various precedents and court rules that govern if and when such testimony can be struck, and the requirements for such testimony to be considered by the court.
I am not a lawyer and have no legal expertise. However, reading these documents, it appears to me that the FTC has a better case than IVDN does. (That is, as far as these four documents go. I have not seen/heard/read any of the testimony in the case itself.)
Note that this is not a criminal case where "beyond a reasonable doubt" exists. This is a civil case where "a preponderance of evidence" is the standard of judgement. (Or so says the guy in the desk next to me who just sat the bar exam.)
I sincerely hope IVDN wins this case. I have many, many shares of IVDN and am not unloading them. But I think that GD's optimism may be a little unwarranted and that each of you deserves the opportunity to see the documents involved firsthand.
Recent IVDN News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 07:23:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 07:15:29 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/26/2024 05:09:52 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 09/27/2023 02:16:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/25/2023 04:53:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/06/2023 08:05:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/07/2023 04:52:57 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM